Short description
BioVex is a biotechnology company developing and commercializing biological treatments for cancer and infectious diseases.
Description
BioVex is a biotechnology company focused on the development and commercialization of biological treatments for cancer and the prevention of infectious disease.
Their cancer program, OncoVEXGM-CSF, is a oncolytic vaccine or cancer destroying virus technology that works by replicating and spreading within solid tumors, causing the death of cancer cells while leaving surrounding healthy cells unharmed. The attenuated virus has also been constructed to induce a powerful systemic anti tumor immune response. OncoVEXGM-CSF has now been tested in >110 patients in a broad range of solid tumors including melanoma, head & neck cancer, breast cancer and pancreatic cancer. Both the direct cell killing and systemic immune mediated mechanisms of action of OncoVEX have been clearly validated in the clinic; OncoVEX routinely destroys tumors it is directly injected into and has led to overall disease responses in multiple patients in Phase II testing. Tumors resolved through OncoVEX treatment have not been known to recur.
Last funding
Cannot Access
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Oxton, York, United Kingdom, Europe
Founded on
January 1, 1999
Exited on
January 25, 2011
Non-profit?
No
Acquired?
No
Employees count
11-50
Investors
Blurry Noaccess, Absolutely Noaccess, Uh Ohhhh, Noaccessforu, Blurry Noaccess, Noaccessforu, Noway Youcantaccess, Absolutely Noaccess, Absolutely Noaccess, Noaccess, Uh Ohhhh, Nopepepe, Blurry Noaccess, Nopepepe, Noaccessforu, Absolutely Noaccess, No Way, Nopepepe, Nopepepe, Absolutely Noaccess, Cannot Access, Noaccess, Blurry Noaccess, Noaccess, Noaccessforu, Nopepepe
Sign in for full access
Founders
David Latchman, Robert Coffin